Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 1: Triazoles, triazolopyrimidines, triazinoindoles, quinoline hydrazones and arylpiperazines
- 1 August 2017
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (16) , 3897-3904
Abstract
No abstract availableKeywords
Funding Information
- Swedish Research Council
- Knut and Alice Wallenberg Foundation
- Göran Gustafsson Foundation
- Swedish Pain Relief Foundation
- Torsten Söderbergs Stiftelse
- Swedish Children's Cancer Foundation
- Swedish Cancer Society
This publication has 18 references indexed in Scilit:
- Mapping the Protein Interaction Landscape for Fully Functionalized Small-Molecule Probes in Human CellsJournal of the American Chemical Society, 2014
- Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategyNature, 2014
- MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP poolNature, 2014
- The NTP pyrophosphatase DCTPP1 contributes to the homoeostasis and cleansing of the dNTP pool in human cellsBiochemical Journal, 2014
- Triptolide Directly Inhibits dCTP PyrophosphataseChemBioChem, 2011
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in BioassaysJournal of Medicinal Chemistry, 2010
- Ligand efficiency as a guide in fragment hit selection and optimizationDrug Discovery Today: Technologies, 2010
- The influence of lead discovery strategies on the properties of drug candidatesNature Reviews Drug Discovery, 2009
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- Dimeric dUTPases, HisE, and MazG belong to a New Superfamily of all-α NTP Pyrophosphohydrolases with Potential “House-cleaning” FunctionsJournal of Molecular Biology, 2005